Literature DB >> 17689593

Fertility-sparing surgery in 101 women with adenocarcinoma in situ of the cervix.

Shawna L Bull-Phelps1, Elizabeth I O Garner, Christine S Walsh, Paola A Gehrig, David S Miller, John O Schorge.   

Abstract

OBJECTIVES: Cervical adenocarcinoma in situ (AIS) is a precursor of invasive disease that is increasing in incidence primarily among reproductive-age women of low parity. Conization is an alternative to hysterectomy that allows future pregnancy, but has an inherent risk of residual AIS. The purpose of this study was to determine the outcomes of patients treated by this fertility-sparing strategy over an extended period of surveillance.
METHODS: Women diagnosed with cervical AIS who underwent primary fertility-sparing surgery with either loop excision or cold knife conization between 1993 and 2001 were identified at three institutions. A retrospective medical record review was performed. Patients 40 years of age and older and those undergoing hysterectomy within 12 months of diagnosis were excluded.
RESULTS: A total of 101 women underwent cone biopsy and expectant management. The median age was 29 years. Fifty-seven percent were nulliparous and 23% primiparous. Cold knife conization was most commonly performed (69 vs. 32 procedures) and had a higher efficacy of achieving negative margins (72% vs. 47%; P=0.036). Thirty-five women had a total of 49 pregnancies during a mean follow-up of 51 months. Thirty-five gestations were delivered at term. There were two preterm births, eight spontaneous miscarriages, three elective terminations, and one ectopic pregnancy. Thirty-six patients had a repeat cone biopsy. Five ultimately underwent hysterectomy. No invasive cervical adenocarcinomas were observed during the study interval.
CONCLUSION: Fertility-sparing surgery enables women with cervical AIS to achieve pregnancy with minimal risk of developing invasive disease during surveillance.

Entities:  

Mesh:

Year:  2007        PMID: 17689593     DOI: 10.1016/j.ygyno.2007.06.021

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  8 in total

1.  Risk of residual disease and invasive carcinoma in women treated for adenocarcinoma in situ of the cervix.

Authors:  Anthony B Costales; Andrea M Milbourne; Helen E Rhodes; Mark F Munsell; John J Wallbillich; Jubilee Brown; Michael Frumovitz; Lois M Ramondetta; Kathleen M Schmeler
Journal:  Gynecol Oncol       Date:  2013-03-28       Impact factor: 5.482

2.  Reproductive outcomes following treatment for a gynecological cancer diagnosis: a systematic review.

Authors:  Brigitte Gerstl; Elizabeth Sullivan; Marcus Vallejo; Jana Koch; Maximilian Johnson; Handan Wand; Kate Webber; Angela Ives; Antoinette Anazodo
Journal:  J Cancer Surviv       Date:  2019-04-17       Impact factor: 4.442

3.  Pattern classification of endocervical adenocarcinoma: reproducibility and review of criteria.

Authors:  Joanne K L Rutgers; Andres A Roma; Kay J Park; Richard J Zaino; Abbey Johnson; Isabel Alvarado; Dean Daya; Golnar Rasty; Teri A Longacre; Brigitte M Ronnett; Elvio G Silva
Journal:  Mod Pathol       Date:  2016-06-03       Impact factor: 7.842

4.  Metastatic adenocarcinoma found in inguinal, pelvic and para-aortic lymph nodes 14 years following hysterectomy for adenocarcinoma in situ of the cervix.

Authors:  Anthony B Costales; Patricia J Eifel; Michael T Deavers; Michael Frumovitz; Kathleen M Schmeler
Journal:  Gynecol Oncol Case Rep       Date:  2012-05-09

Review 5.  Comparison of Cold-Knife Conization versus Loop Electrosurgical Excision for Cervical Adenocarcinoma In Situ (ACIS): A Systematic Review and Meta-Analysis.

Authors:  Yanming Jiang; Changxian Chen; Li Li
Journal:  PLoS One       Date:  2017-01-26       Impact factor: 3.240

Review 6.  Diagnosis and Management of Adenocarcinoma in Situ: A Society of Gynecologic Oncology Evidence-Based Review and Recommendations.

Authors:  Deanna Teoh; Fernanda Musa; Ritu Salani; Warner Huh; Edward Jimenez
Journal:  Obstet Gynecol       Date:  2020-04       Impact factor: 7.623

7.  Excisional treatment in women with cervical adenocarcinoma in situ (AIS): a prospective randomised controlled non-inferiority trial to compare AIS persistence/recurrence after loop electrosurgical excision procedure with cold knife cone biopsy: protocol for a pilot study.

Authors:  Paul A Cohen; Alison Brand; Peter Sykes; David C H Wrede; Orla McNally; Lois Eva; Archana Rao; Michael Campion; Martin Stockler; Aime Powell; Jim Codde; Max K Bulsara; Lyndal Anderson; Yee Leung; Louise Farrell; Pennie Stoyles
Journal:  BMJ Open       Date:  2017-08-28       Impact factor: 2.692

8.  Oncological and reproductive outcomes of adenocarcinoma in situ of the cervix managed with the loop electrosurgical excision procedure.

Authors:  Huimin Bai; Jun Liu; Qiuxi Wang; Ying Feng; Tong Lou; Shuzhen Wang; Yue Wang; Mulan Jin; Zhenyu Zhang
Journal:  BMC Cancer       Date:  2018-04-24       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.